{"entity":{"type":"insider","cik":"0001553599","url":"/insider/0001553599","json_url":"/insider/0001553599.json","name":"Flynn Karen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":11,"first":"2013-11-19","last":"2026-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Flynn Karen","source":"filing","n_filings":11,"first_seen":"2013-11-19","last_seen":"2026-06-26"}],"transactions":[{"id":5859911,"accession":"0001193125-26-283788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-283788","line_url":"/filing/0001193125-26-283788#line-2","is_derivative":false,"issuer_cik":"0001553599","issuer_name":"Stevanato Group S.p.A.","issuer_ticker":"STVN","issuer_name_source":null,"issuer_url":"/issuer/0001553599","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1493.0,"shares_display":"1,493","price_per_share":17.09,"price_display":"17.09","price_state":"stated","total_value":25515.37,"total_display":"25,515.37","total_whole":"25,515","shares_owned_after":5757.0,"shares_owned_after_display":"5,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-26","scope":"insider"},{"id":6499080,"accession":"0001596783-22-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596783-22-000014","line_url":"/filing/0001596783-22-000014#line-1","is_derivative":false,"issuer_cik":"0001553599","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001553599","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2472.0,"shares_display":"2,472","price_per_share":116.64,"price_display":"116.64","price_state":"stated","total_value":288334.08,"total_display":"288,334.08","total_whole":"288,334","shares_owned_after":33223.0,"shares_owned_after_display":"33,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider"},{"id":4278551,"accession":"0001596783-21-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001596783-21-000026","line_url":"/filing/0001596783-21-000026","is_derivative":false,"issuer_cik":"0001553599","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001553599","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (Pres. Biologics & CCO)","role_mark":"O","role_mark_label":"Officer (Pres. Biologics & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Biologics & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2478.0,"shares_display":"2,478","price_per_share":112.29980629539952,"price_display":"112.30","price_state":"stated","total_value":278278.92,"total_display":"278,278.92","total_whole":"278,279","shares_owned_after":35644.0,"shares_owned_after_display":"35,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-11","scope":"insider","n_lines":2},{"id":4577182,"accession":"0001596783-21-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596783-21-000014","line_url":"/filing/0001596783-21-000014#line-1","is_derivative":false,"issuer_cik":"0001553599","issuer_name":"Catalent, Inc.","issuer_ticker":"CTLT","issuer_name_source":null,"issuer_url":"/issuer/0001553599","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (Pres. Biologics & CCO)","role_mark":"O","role_mark_label":"Officer (Pres. Biologics & CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. Biologics & CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":104.42,"price_display":"104.42","price_state":"stated","total_value":10337.58,"total_display":"10,337.58","total_whole":"10,338","shares_owned_after":37022.0,"shares_owned_after_display":"37,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":6597644,"accession":"0001562180-18-003539","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-003539","line_url":"/filing/0001562180-18-003539#line-3","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (Sr VP & Chief Commercial Offic)","role_mark":"O","role_mark_label":"Officer (Sr VP & Chief Commercial Offic)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP & Chief Commercial Offic","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20458.0,"shares_display":"20,458","price_per_share":116.23,"price_display":"116.23","price_state":"stated","total_value":2377833.34,"total_display":"2,377,833.34","total_whole":"2,377,833","shares_owned_after":21593.1476,"shares_owned_after_display":"21,593.15","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-09","scope":"insider"},{"id":3321705,"accession":"0001123292-16-003076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-003076","line_url":"/filing/0001123292-16-003076#line-1","is_derivative":false,"issuer_cik":"0001553599","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001553599","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":6.705,"price_display":"6.70","price_state":"stated","total_value":5364.0,"total_display":"5,364.00","total_whole":"5,364","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-19","scope":"insider"},{"id":3262427,"accession":"0001225208-16-038910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-16-038910","line_url":"/filing/0001225208-16-038910#line-1","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (Sr VP & Chief Commercial Offic)","role_mark":"O","role_mark_label":"Officer (Sr VP & Chief Commercial Offic)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP & Chief Commercial Offic","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14581.0,"shares_display":"14,581","price_per_share":83.28,"price_display":"83.28","price_state":"stated","total_value":1214305.68,"total_display":"1,214,305.68","total_whole":"1,214,306","shares_owned_after":13512.549,"shares_owned_after_display":"13,512.55","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-07","scope":"insider"},{"id":8262765,"accession":"0001225208-15-020758","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-15-020758","line_url":"/filing/0001225208-15-020758#line-3","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (President, Pharma Pckg Systems)","role_mark":"O","role_mark_label":"Officer (President, Pharma Pckg Systems)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Pharma Pckg Systems","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18020.0,"shares_display":"18,020","price_per_share":63.0257,"price_display":"63.03","price_state":"stated","total_value":1135723.114,"total_display":"1,135,723.11","total_whole":"1,135,723","shares_owned_after":24609.83,"shares_owned_after_display":"24,609.83","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-12","scope":"insider"},{"id":8504459,"accession":"0001225208-15-012737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-15-012737","line_url":"/filing/0001225208-15-012737#line-2","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (President, Pharma Pckg Systems)","role_mark":"O","role_mark_label":"Officer (President, Pharma Pckg Systems)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Pharma Pckg Systems","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3091.0,"shares_display":"3,091","price_per_share":55.2367,"price_display":"55.24","price_state":"stated","total_value":170736.6397,"total_display":"170,736.64","total_whole":"170,737","shares_owned_after":24609.83,"shares_owned_after_display":"24,609.83","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-22","filed_date":"2015-05-26","scope":"insider"},{"id":8157527,"accession":"0001225208-15-012361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-15-012361","line_url":"/filing/0001225208-15-012361#line-2","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (President, Pharma Pckg Systems)","role_mark":"O","role_mark_label":"Officer (President, Pharma Pckg Systems)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, Pharma Pckg Systems","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1909.0,"shares_display":"1,909","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":104995.0,"total_display":"104,995.00","total_whole":"104,995","shares_owned_after":24609.83,"shares_owned_after_display":"24,609.83","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-18","filed_date":"2015-05-19","scope":"insider"},{"id":4796035,"accession":"0001225208-13-023877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-13-023877","line_url":"/filing/0001225208-13-023877#line-2","is_derivative":false,"issuer_cik":"0000105770","issuer_name":"WEST PHARMACEUTICAL SERVICES INC","issuer_ticker":"WST","issuer_name_source":null,"issuer_url":"/issuer/0000105770","owner_cik":"0001553599","owner_name":"Flynn Karen","owner_display_name":"Flynn Karen","owner_url":"/insider/0001553599","role":"Officer (President, America's Region)","role_mark":"O","role_mark_label":"Officer (President, America's Region)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, America's Region","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":47.75,"price_display":"47.75","price_state":"stated","total_value":262625.0,"total_display":"262,625.00","total_whole":"262,625","shares_owned_after":10535.8092,"shares_owned_after_display":"10,535.81","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001849853","name":"Stevanato Group S.p.A.","url":"/issuer/0001849853","role":"Director","n_filings":1,"first_seen":"2026-06-26","last_seen":"2026-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001596783","name":"Catalent, Inc.","url":"/issuer/0001596783","role":"Officer (Chief Commercial Officer)","n_filings":3,"first_seen":"2021-01-05","last_seen":"2022-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000105770","name":"WEST PHARMACEUTICAL SERVICES INC","url":"/issuer/0000105770","role":"Officer (Sr VP & Chief Commercial Offic)","n_filings":6,"first_seen":"2013-11-19","last_seen":"2018-08-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Director","n_filings":1,"first_seen":"2016-12-19","last_seen":"2016-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553599","retrieved_at":"2026-08-23T21:52:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}